VersaTrial
Financials
Estimates*
EUR | 2023 |
---|---|
Revenues | 1.1m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $2.4m | Seed | |
* | N/A | Acquisition | |
Total Funding | AUD3.7m |
Related Content
Recent News about VersaTrial
EditVersaTrial operates in the clinical research industry, providing a browser-based platform designed to streamline the management of clinical trials. The company serves clinical research coordinators, principal investigators, and other stakeholders involved in clinical trials. VersaTrial's platform automates tedious tasks such as outreach, reminders, tracking, and collection of responses, thereby saving time and improving efficiency. The platform also centralizes various links and resources into one searchable, shareable location, accessible by the entire team. This includes saving feasibility questionnaire responses to an intelligent answer library, which can be auto-completed for future use. VersaTrial's business model is likely subscription-based, generating revenue through recurring fees from its clients. The company aims to enhance the efficiency and effectiveness of clinical trials, making the process smoother and more manageable for its users.
Keywords: clinical trials, automation, outreach, tracking, response collection, feasibility questionnaires, browser-based, research coordinators, principal investigators, time-saving.